Le Lézard
Classified in: Health, Science and technology, Business
Subjects: TNM, ANW

Neogen plans to acquire U.S. rights and related assets to Elanco's StandGuard® insecticide


LANSING, Mich., July 16, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that, in line with yesterday's Federal Trade Commission (FTC) press release, it plans to acquire the U.S. (including territories) rights to Elanco's StandGuard® Pour-on for horn fly and lice control in beef cattle, and related assets. Closing remains subject to a final FTC consent decree for closing of Elanco's acquisition of Bayer AG's global animal health business.

StandGuard Pour-on is one of the leading products in the domestic beef cattle insecticide market, and represents an exceptional fit in Neogen's existing agricultural insecticide portfolio and organizational capabilities. Neogen entered the agricultural insecticide market with its 2014 acquisition of Chem-Tech.

"Elanco's divestiture of its StandGuard product is an unexpected opportunity that we could not pass on," said John Adent, Neogen's president and chief executive officer. "The product is a true bolt-on to complement our existing agricultural biosecurity infrastructure. This acquisition will provide Neogen immediate sales opportunities post-closing, along with both new registrations and access to the gamma-cyhalothrin active."

Neogen's 2014 acquisition of Chem-Tech brought the company Prozap®, an insecticide brand that is well known in the large animal production industry, and is particularly popular with dairy and equine producers, and an extensive manufacturing and distribution facility in Pleasantville, Iowa.

Terms of the agreement were not disclosed.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACT:

Steve Quinlan, Vice President & CFO


Neogen Corporation, 517/372-9200

 

SOURCE Neogen Corporation


These press releases may also interest you

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Perion...

at 22:35
President Xi Jinping left Budapest on Friday, wrapping up his fruitful three-nation Europe visit, which both Chinese and European analysts believe injects momentum into China-Europe relations as well as future multipolarity and global stability. At...

at 22:22
IT Tech Packaging, Inc. ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced its unaudited financial results for the first quarter ended March 31, 2024. Mr....

at 22:19
TSX VENTURE COMPANIES NEX COMPANY BULLETIN V2024-1406 MUST CAPITAL INC. ("MUST.H")BULLETIN TYPE: Resume TradingBULLETIN DATE: May 10, 2024NEX CompanyFurther to the Company's press release dated March 7, 2024, effective at the opening on Tuesday, May...

at 22:00
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 21:29
The Forum of Ministers Responsible for Immigration (FMRI) met today to discuss Canada's immigration levels planning for 2025?2027. Canada's immigration ministers discussed the economic and social benefits of immigration, levels of permanent and...



News published on and distributed by: